Abstract | AIM: METHODS: Rat hemorrhagic shock model (40 mmHg) and vascular smooth muscle cell (VSMC) hypoxic model were used. The expression of A(3)AR was determined by Western blot and RT-PCR. The effect of A(3)AR stimulation on RyR-mediated Ca(2+) release in VSMCs was analyzed by the Fura-3/AM loading Ca(2+) imaging. The modulation of vascular reactivity to norepinephrine (NE) by A(3)AR stimulation was monitored by an isolated organ tension instrument. RESULTS: Decrease of A(3)AR expression is consistent with the loss of vasoreactivity to NE in hemorrhagic shock rats. The stimulation of A(3)AR with a selective agonist, IB-MECA, could partly but significantly restore the vasoreactivity in the rats, and this restorative effect could be counteracted by MRS1523, a selective A(3)AR antagonist. In hypoxic VSMCs, RyR activation by caffeine significantly evoked the rise of [Ca(2+)] compared with the control cells, a phenomenon closely associated with the development of vascular hyporeactivity in hemorrhagic shock rats. The stimulation of A(3)AR with IB-MECA significantly blocked this over activation of RyR-mediated Ca(2+) release. RyR activation by caffeine and BK(Ca) channel activation by NS1619 attenuated the restoration of vasoreactivity to NE resulting from A(3)AR stimulation by IB-MECA after hemorrhagic shock; this attenuation effect could be antagonized by a selective BK(Ca) channel blocker. CONCLUSION: These findings suggest that A(3)AR is involved in the modulation of vasoreactivity after hemorrhagic shock and that stimulation of A(3)AR can restore the decreased vasoreactivity to NE through a RyR-mediated, BK(Ca) channel-dependent signal pathway.
|
Authors | Rong Zhou, Feng Chen, Qiang Li, De-yao Hu, Liang-ming Liu |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 31
Issue 4
Pg. 413-20
(Apr 2010)
ISSN: 1745-7254 [Electronic] United States |
PMID | 20348945
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Large-Conductance Calcium-Activated Potassium Channels
- Receptor, Adenosine A3
- Ryanodine Receptor Calcium Release Channel
- Vasoconstrictor Agents
- Calcium
- Norepinephrine
|
Topics |
- Animals
- Aorta, Abdominal
(cytology)
- Calcium
(metabolism)
- Cell Hypoxia
(drug effects)
- Cells, Cultured
- Gene Expression
- Large-Conductance Calcium-Activated Potassium Channels
(metabolism)
- Muscle, Smooth, Vascular
(cytology, drug effects)
- Norepinephrine
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Rats, Wistar
- Receptor, Adenosine A3
(genetics, metabolism)
- Ryanodine Receptor Calcium Release Channel
(metabolism)
- Shock, Hemorrhagic
(metabolism)
- Vasoconstriction
(drug effects)
- Vasoconstrictor Agents
(pharmacology)
|